\
&
Contact us
\
&
Contact us
Published on | 9 months ago
Programmes HealthThe European Partnership for Personalised Medicine (EP PerMed) has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over € 36.5 Mio.
The topics of this call are the following:
Pay attention: projects focussing only on drug-drug-interaction and projects focusing on the clinical development of new drugs are not eligible.
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on how to apply can be found on the dedicated FWO webpage. Interested to apply? Contact the FWO advisors at europe@fwo.be. Deadline for pre-proposal submission AND national pre-application via the FWO e-loket is 18 February 2025, 14:00 CET.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
